A set of diagnostic-focused studies and imaging tools aim to improve risk stratification and decision-making before or during treatment. A dual-center MRI radiomics-and-AI nomogram for advanced rectal cancer validated a method to predict preoperative tumor deposits, combining T2-weighted MRI features with deep learning and CA19-9. In pediatric glioma, a locked 15-microRNA diagnostic model reportedly identified diffuse intrinsic pontine glioma with 95.6% accuracy in an independent retrospective test cohort. For prostate cancer, PSMA PET/CT staging reportedly detected recurrence before the Phoenix threshold with reliable performance in a retrospective cohort. Across these reports, the theme is earlier detection and more precise selection of next steps using noninvasive markers, with multiple strategies spanning radiomics, molecular assays, and PET imaging.